Evidence map›Paper›PMID 35072929›Full record

ReviewCurrent allergy and asthma reports2022

Therapies for Olfactory Dysfunction - an Update.

Aria Jafari, Eric H Holbrook

Open access · hybridAbstract readReview
In one paragraph

Review in Current allergy and asthma reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
5.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Effects of Mechanical Nasal Stimulation on Olfaction.Medical devices (Auckland, N.Z.) · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Stem Cell Niches for Olfactory Regeneration and Their Therapeutic Applications.Journal of rhinology : official journal of the Korean Rhinologic Society · 2025
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Long-term smell loss experiences after COVID-19: A qualitative study.Health expectations : an international journal of public participation in health care and health policy · 2024
    Article
  17. Article
  18. Effects of Endoscopic Sinus Surgery on Olfactory Function.Current allergy and asthma reports · 2023
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Aria JafariDepartment of Otolaryngology-Head & Neck Surgery, Division of Rhinology and Endoscopic Skull Base Surgery, University of Washington, Seattle, WA, 98195-6515, USA. ajafari@uw.edu.ORCID 0000-0002-5254-3221
Eric H HolbrookDepartment of Otolaryngology-Head & Neck Surgery, Harvard Medical School, Massachusetts Eye and Ear, Boston, MA, USA.
Massachusetts Eye and Ear Infirmary · USUniversity of Washington · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewOlfactory dysfunction is a prevalent condition affecting 5-15% of the general population, with significant impact on quality of life. This review summarizes the most recent and relevant literature in the treatment of olfactory dysfunction. RECENT

findingsCurrent evidence supports the short-term use of topical corticosteroids and systemic therapy. These treatments may occur in conjunction with olfactory training, which is well supported by the literature. While there are several additional treatments currently under investigation, meaningful conclusions are not yet able to be made regarding their efficacy. The treatment of olfactory dysfunction is targeted at the suspected etiology when possible. After normal aging, chronic rhinosinusitis, post-infectious sequelae including as a result SARS-CoV-2 infection (COVID-19), and head trauma are the most common causes. Current evidence supports the short-term use of topical corticosteroids and systemic therapy. Several additional treatments are under investigation but recommendations for their use cannot currently be made.

Indexed as

COVID-19COVID-19 Drug TreatmentOlfaction DisordersHumansQuality of LifeSARS-CoV-2SmellAnosmiaOlfactionOlfaction disorderOlfactory impairmentSmell disorderSmell loss

Identifiers

PMID35072929
PMCPMC8785376
OpenAlexW4206939194

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.